Targeting Kynurenine Synthesis Attenuated Cigarette Smoke‐Induced COPD‐Like Lung Injury Driven by TALDO1‐Mediated Metabolic Reprogramming
Advanced Science · 11.11.2026
DOI: 10.1002/advs.78795 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 11.11.2026. Verfasst von Wenjing Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Diseases, Guangzhou Institute of Respiratory Health, …. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Project of Guangzhou National Laboratory, Foundation of Guangzhou National Laboratory, National Natural Science Foundation of China.
Themen: COPD
Abstract (Originalsprache)
Chronic obstructive pulmonary disease (COPD) is a devastating condition characterized by airflow limitation, inflammation, and structural lung damage. Metabolic dysregulation is recognized as a critical feature, but the key metabolic drivers remain unclear. This study identifies transaldolase1 (TALDO1) as a previously unrecognized metabolic regulator in cigarette smoke (CS)‐induced COPD pathogenesis. TALDO1 is markedly upregulated in airway epithelial cells by CS exposure. Elevated TALDO1 promotes mitochondrial dysfunction, whereas its genetic knockdown attenuates CS‐induced lung function decline and pulmonary inflammation. Mechanistically, TALDO1 activation redirects tryptophan metabolism toward the kynurenine pathway, leading to L‐kynurenine accumulation. Genetic or pharmacological inhibition of this pathway significantly alleviates mitochondrial damage, while L‐kynurenine supplementation exacerbates injury. Treatment with the IDO inhibitor Epacadostat ameliorates CS‐induced lung impairment and inflammation in vivo. These findings define a TALDO1‐kynurenine‐mitochondrial injury axis linking airway epithelial metabolic reprogramming to COPD, providing translational evidence for targeting this pathway as a therapeutic strategy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Diseases, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzh…
- Guangzhou National Laboratory, Guangzhou, Guangdong, China.
- GMU-GIBH Joint School of Life Sciences, Guangzhou Medical University, Guangzhou, China.
ORCID-Profile: Wenjing Wang, Haiqing Li, Wei Tu, Pixin Ran
Förderung
- Major Project of Guangzhou National Laboratory
- Foundation of Guangzhou National Laboratory
- National Natural Science Foundation of China
- Young Scientists Program of Guangzhou National Laboratory
Zitieren
APA
Wang, W., Wu, M., Yang, Y., Chen, Z., Yan, J., Jin, X., Cui, Y., Zhang, F., Li, H., Chen, W., Zhou, Y., Zhu, L., Tu, W., & Ran, P. (2026). Targeting Kynurenine Synthesis Attenuated Cigarette Smoke‐Induced COPD‐Like Lung Injury Driven by TALDO1‐Mediated Metabolic Reprogramming. Advanced Science. https://doi.org/10.1002/advs.78795
Vancouver
Wang W, Wu M, Yang Y, Chen Z, Yan J, Jin X, et al. Targeting Kynurenine Synthesis Attenuated Cigarette Smoke‐Induced COPD‐Like Lung Injury Driven by TALDO1‐Mediated Metabolic Reprogramming. Advanced Science. 2026. doi:10.1002/advs.78795
BibTeX
@article{Wang2026,
author = {Wang, Wenjing and Wu, Mindan and Yang, Yuanlan and Chen, Zemin and Yan, Jiawei and Jin, Xuan and Cui, Yachao and Zhang, Feng and Li, Haiqing and Chen, Wensheng and Zhou, Yumin and Zhu, Leqing and Tu, Wei and Ran, Pixin},
title = {Targeting Kynurenine Synthesis Attenuated Cigarette Smoke‐Induced COPD‐Like Lung Injury Driven by TALDO1‐Mediated Metabolic Reprogramming},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.78795}
}
EUVIMED